Becker's Healthcare November 26, 2024
Should employers, patients, or insurers bear the largest share of an annual $411 billion cost?
The U.S. healthcare industry is contending with the question amid the boom of GLP-1 popularity.
List prices for popular GLP-1 medicines are about $1,000 for a four-week supply. Citing high costs and demand, some employers and insurance plans have trimmed or ended GLP-1 coverage.
In mid-2024, 44% of employers with 500 or more employees offered coverage for GLP-1 obesity drugs, according to consulting firm Mercer. GLP-1 drugmakers Eli Lilly and Novo Nordisk are working to increase this percentage as they tell employers this coverage will bring long-term cost savings.
On Nov. 26, the Biden administration shared a proposal for Medicare and Medicaid to...
Today's Sponsors
Today's Sponsor